Correction to: Clinical and Experimental Nephrology https://doi.org/10.1007/s10157-018-1632-9
In the original publication of the article, two sentences in the “Results” section were published incorrectly. The corrected texts are provided below:
-
1.
In the first paragraph of the section “Effectiveness”, 10th line should read as “The administered dose of darbepoetin (mean ± SD, µg) in the effectiveness analysis”.
-
2.
In the fourth paragraph of the section “Effectiveness”, 1st line should read as “Female patients or those with advanced age…baseline systolic blood pressure ≥ 130 mmHg”.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tanaka, T., Nangaku, M., Imai, E. et al. Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan. Clin Exp Nephrol 23, 435 (2019). https://doi.org/10.1007/s10157-019-01694-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-019-01694-w